HPV Vaccine Initiative Launched in Mysuru, Karnataka

Reaction from the field

A free HPV vaccination drive was launched at Bharath Cancer Hospital in Mysuru, Karnataka, marking a significant step in the fight against cervical cancer. This initiative aims to create awareness about cervical cancer prevention among women, addressing a pressing health concern that affects many in the region.

The program will provide free HPV vaccinations to the first 200 registered beneficiaries, highlighting the urgency and importance of early intervention. Cervical cancer is the second most common cancer among women globally, with India reporting approximately 1.23 lakh new cases each year. The initiative is particularly timely, as around 67,500 women succumb to cervical cancer in India annually.

The HPV vaccine is most effective for individuals aged between 9 to 14 years, making it crucial to target this demographic for vaccination. On February 28, 2026, the Government of India launched a single-shot HPV vaccination program specifically for girls aged 14 years, with a target of achieving 1.15 crore vaccinations each year. This ambitious goal underscores the government’s commitment to combating cervical cancer through preventive measures.

The HPV vaccine has received approval from India’s drug regulator, and the Gates Foundation is involved in the supply procurement of the vaccine in the country. Currently, the vaccine is available at primary health centers, Community Health Centres, District Health Centres, and government hospitals across Mandya district, ensuring accessibility for those in need.

Dr. Nagalakshmi Choudhary expressed pride in inaugurating such a meaningful program, emphasizing the importance of addressing cervical cancer as a major health concern for women. Dr. C.B. Avinash echoed these sentiments, stating that cervical cancer continues to be a significant health issue that requires immediate attention.

The vaccination campaign in Mandya aims to identify all eligible girls within the next month, ensuring that the benefits of the HPV vaccine reach those who need it most. However, Kumara, a health official, noted that misconceptions and confusion about the vaccine among children and parents must be addressed through proper awareness initiatives.

Despite these positive developments, uncertainties remain regarding the effectiveness of the HPV vaccination program in reducing cervical cancer rates in India. Additionally, concerns about the influence of foreign organizations on India’s health policymaking are not fully resolved. Details remain unconfirmed, and stakeholders are keenly observing the program’s progress and its potential impact on public health.